Nasogastric Tube Market Size, Share & Trends Analysis Report By Type  (Single-lumen Tubes, Double-lumen Tubes), By Application  (Medication Administration, Gastric Suctioning, Others), By End-User (Hospitals, Specialty Clinics, Homecare, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Nasogastric Tube Market Size

The global nasogastric tube market size was valued at USD 557.87 million in 2024 and is projected to grow from USD 590.64 million in 2025 to reach USD 852.81 million by 2033, exhibiting a CAGR of 4.7% during the forecast period (2025-2034).

A nasogastric (NG) tube is a flexible medical device used for feeding patients who are unable to ingest food or fluids orally. Inserted through the nose, down the esophagus, and into the stomach, an NG tube facilitates the delivery of nutrients, medications, and fluids directly to the stomach, or it can be used to remove stomach contents, such as in cases of poisoning or post-surgery recovery. This device is commonly used for short-term feeding in patients with conditions like difficulty swallowing, neurological disorders, or post-operative care.

The market is experiencing steady growth, driven by the increasing demand for enteral nutrition solutions and advancements in tube materials and design. The rising prevalence of chronic diseases such as gastrointestinal disorders, neurological conditions, and cancer has heightened the need for NG tubes in both acute and homecare settings. Likewise, technological innovations—such as closed-system feeding, anti-clogging coatings, smart feeding systems, and radiopaque markings—are improving patient safety and ease of use, further propelling market expansion.

Another key driver of growth is the shift towards home-based enteral nutrition, spurred by cost-reduction strategies within the healthcare industry. The growing application of NG tubes in pediatric and geriatric care is also contributing to market growth, with an increased focus on patient-friendly solutions that enhance comfort and minimize complications. Moreover, strategic partnerships and innovations, including biocompatible tubing materials and smart feeding systems, are expanding market opportunities.

As healthcare providers and manufacturers continue to prioritize safety, efficiency, and patient-centric designs, the nasogastric tube market is poised for sustained growth, with a particular focus on minimally invasive and effective enteral feeding technologies.

Nasogastric Tube Market Trends

Technological advancements

Innovations such as the use of biocompatible materials, anti-clogging designs, and advanced insertion techniques have significantly enhanced patient comfort and safety, propelling the global market.

For instance,

• In November 2024, Avanos Medical, Inc. launched the CORGRIP SR Nasogastric Tube Retention System, featuring a monofilament thread for better tube security. Designed to reduce dislodgement and replacement complications, it offers a superior alternative to tape-based fixation, enhancing patient comfort and safety.
• Likewise, in March 2023, Gravitas Medical Inc. received FDA clearance for its entarik feeding tube system, featuring a sensor-based nasogastric tube and monitor. The system provides real-time enteral nutrition intelligence, enabling caregivers to make timely decisions, reduce complications, and improve patient outcomes.

Adoption of closed-system feeding

Closed-system feeding methods are gaining traction as they reduce infection risks, minimize contamination, and improve patient safety during enteral feeding. These systems come pre-filled, sealed, and ready for direct administration, lowering the chances of bacterial exposure compared to open systems.

• For instance, in November 2022, Rockfield Medical Devices Limited received FDA clearance for its mobility enteral feeding system, a portable, lightweight, and non-electronic solution for tube-fed patients aged 2 years and older. Designed for clinical and home care settings, the system consists of a food pouch, filling set, and giving set, enabling convenient 24-hour use.

Such innovations in closed-system feeding continue to enhance infection control, patient convenience, and overall healthcare outcomes, boosting the global nasogastric tube market.

Nasogastric Tube Market Growth Factors

Rising prevalence of chronic diseases

The increasing prevalence of chronic diseases such as cancer, neurological disorders, gastrointestinal diseases, and diabetes is a major driver of the nasogastric (NG) tube market. Many of these conditions lead to dysphagia, malnutrition, or the need for enteral feeding. Boosting the usage of nasogastric tubes in health care settings.

• For instance, in October 2024, the U.S. Centres for Disease Control and Prevention (CDC) reported that 6 in 10 Americans have at least one chronic disease, while 4 in 10 suffer from two or more. Many of these conditions, often linked to poor nutrition and lifestyle factors, lead to dysphagia, malnutrition, or gastrointestinal complications, increasing the need for nasogastric tubes in hospitals and long-term care.

The growing burden of chronic diseases is fuelling the demand for nasogastric tubes in healthcare settings, driving market growth.

Increased surgical procedures

The rising number of surgical procedures globally is a key driver of the nasogastric (NG) tube market, as these tubes are widely used for preoperative and postoperative care to prevent aspiration, aid in gastric decompression, and support enteral feeding. The growing incidence of gastrointestinal, bariatric, and cancer-related surgeries is fuelling demand for NG tubes.

• For instance, in May 2024, an article published in the National Library of Medicine reported a 6.5% increase in bariatric surgery volumes in 2022. This rise in weight-loss procedures has contributed to the growing demand for nasogastric tubes, which are essential for postoperative gastric decompression and enteral feeding.

The increase in surgical volumes is driving the demand for nasogastric tubes, emphasizing their critical role in perioperative management and supporting patient recovery processes.

Market Restraining Factors

Availability of alternative feeding methods

The availability of alternative feeding methods, such as percutaneous endoscopic gastrostomy (PEG) tubes, jejunostomy tubes, and oral nutritional supplements, presents a significant restraint to the growth of the nasogastric (NG) tube market. These alternatives are particularly beneficial in cases where long-term feeding support is required, offering better patient comfort and therapeutic efficacy compared to NG tubes. PEG and jejunostomy tubes, for example, are often preferred for long-term feeding due to their reduced risk of complications, such as nasal irritation or aspiration. As these alternatives become more widely accessible and preferred for chronic care, the demand for NG tubes is likely to face limitations.

Market Opportunity

Growth in home healthcare settings

As more patients require long-term care and enteral feeding at home, there is an increasing demand for portable, easy-to-use nasogastric tubes that ensure patient comfort and safety in a home environment. With advancements in closed-system feeding and patient-friendly designs, NG tubes are becoming more adaptable for home-based care, boosting market growth.

• For instance, in November 2022, nfant launched the nfant thrive feeding system, a connected device designed to enhance baby feeding using advanced technology. The company also partnered with SimpliFed, a telehealth platform, to provide virtual lactation and feeding support, promoting infant growth and development. This highlights the growing need for home healthcare solutions.

The rise in home-based healthcare creates more opportunities for the nasogastric tubes market, with innovations aimed at making these tubes more convenient and safer for home use.

Regional Insights

North America: Dominant region with 38.16% market share

North America maintains a dominant position in the global nasogastric tube market, driven by substantial healthcare expenditure, sophisticated medical infrastructure, and an increasing prevalence of chronic conditions such as diabetes, cancer, and neurological disorders. The region's healthcare system supports the demand for advanced enteral feeding solutions, with innovations in NG tube design enhancing patient comfort, safety, and ease of use, especially in home care settings.

Moreover, the strong presence of key manufacturers and ongoing technological advancements, such as smart feeding systems, further bolster market growth. The rising preference for minimally invasive procedures and patient-centric solutions also drives demand for NG tubes, particularly in the U.S. and Canada.

Asia Pacific: Fastest growing region with the highest market CAGR

Asia-Pacific is set to experience the fastest CAGR in the market for nasogastric tube during the forecast period. This is due to the increasing burden of chronic diseases such as cancer, diabetes, and neurological disorders, which require long-term enteral feeding solutions. The region's improving healthcare infrastructure, heightened awareness about nutritional support, and increasing government investments in healthcare are all contributing to the rapid expansion of the market. Moreover, the rise in home care services, driven by cost-effective and patient-friendly solutions, is further fueling the demand for nasogastric tubes.

Countries Insights

• U.S.- The U.S. nasogastric tube market remains a dominant force, propelled by significant investments in research and development, along with the launch of innovative products by leading manufacturers. In September 2023, Cardinal Health introduced the Kangaroo OMNI enteral feeding pump, a groundbreaking, attitude-independent system that delivers thick formulas with enhanced portability. This advancement enhances the convenience of feeding, flushing, hydrating, and tracking over 30 days of feeding history, meeting the growing demands for patient care.
• Germany- Germany stands as one of the largest markets for nasogastric tubes in Europe, supported by regulatory approvals and the expansion of manufacturing facilities. Notably, RAUMEDIC completed the ISCC PLUS certification in November 2024, allowing the company to produce sustainable PVC medical tubing. By replacing fossil-based polymers with bio-attributed alternatives, RAUMEDIC aims to minimize the environmental impact of medical device production. This move aligns with the industry's growing focus on sustainability while continuing to meet the demand.
• Canada- Canada's nasogastric tube industry is expanding, driven by an increasing prevalence of chronic diseases like diabetes and cancer and the rising number of surgeries requiring postoperative NG tube usage. Moreover, the market is benefiting from medical technological advancements and improvements in homecare services, which are making nasogastric tube adoption more widespread. As more patients seek long-term nutritional support, the demand for enteral feeding solutions is expected to grow, further boosting the market's potential.
• India– India's market for nasogastric tube is experiencing rapid growth, fueled by strategic partnerships and the rising demand for enteral feeding solutions. In April 2024, Nestlé India and Dr. Reddy’s Laboratories formed a joint venture focused on expanding nutraceutical portfolios in hospital nutrition and wellness. This collaboration is expected to drive increased demand for nasogastric tubes as more patients require nutritional support in both hospital and homecare settings, contributing to the broader adoption of advanced medical technologies across the country.
• Japan- Japan’s nasogastric tube market is experiencing significant growth, fueled by a high prevalence of chronic diseases like diabetes, stroke, and cancer. These conditions are driving the demand for enteral feeding solutions as more patients require long-term nutritional support. Advancements in medical technology, particularly those aimed at improving patient comfort, are encouraging greater adoption of NG tubes. Moreover, Japan’s well-established healthcare infrastructure and focus on enhancing homecare services are contributing to the overall growth.

Segmentation Analysis

By Type

Single-lumen tubes lead the market due to their simplicity, affordability, and versatility. These tubes are widely used in short-term enteral feeding, gastric decompression, and drainage, making them an ideal choice for routine medical procedures. Their easy insertion and lower risk of complications have contributed to their dominant position in the market. Moreover, their cost-effectiveness and ease of use in both acute and chronic care settings ensure their continued demand, particularly in low-resource settings.

By Application

Gastric suctioning remains the largest application segment in the market due to its crucial role in managing gastric pressure and preventing aspiration in patients with gastrointestinal disorders. These tubes are essential for removing gastric contents in cases of intestinal obstructions, post-operative care, and during acute care procedures, especially in critically ill patients. Gastric suctioning helps alleviate complications and reduces the risk of aspiration pneumonia, ensuring optimal patient outcomes.

By End-User

Hospitals dominate the market, driven by the high volume of acute care procedures that require enteral feeding, gastric decompression, and medication administration. NG tubes are critical for patients in emergency and post-operative settings, where quick and effective solutions for nutrition and drainage are vital. The presence of skilled healthcare professionals and advanced medical facilities in hospitals ensures optimal utilization of NG tubes, further reinforcing their dominance in this segment.

Company Market Share

Key players in the industry are increasingly focusing on adopting a range of business strategies to strengthen their position in the market. These strategies include strategic collaborations, product approvals, acquisitions, and product launches, which are designed to expand their market share and enhance product offerings. Companies are also investing heavily in research and development to introduce innovative and more effective products.

Rockfield Medical Devices Limited: An emerging player in the market

Rockfield Medical Devices Limited specializes in creating innovative solutions tailored for patients requiring enteral feeding, with a strong focus on patient-centered care. The company is committed to enhancing the quality of life for individuals, particularly in homecare settings, by developing advanced products that prioritize comfort, convenience, and safety.

Recent developments by Rockfield Medical Devices Limited:

• In May 2024, Rockfield Medical Devices Limited received FDA OTC clearance for its mobility enteral feeding system, enabling it to be sold directly to consumers without a prescription. Designed for homecare settings, this lightweight, non-electronic system enhances patient mobility and independence while improving ease of use for enteral feeding, offering broader access to enteral nutrition products.

Recent Developments

• July 2024 – Dale Medical Products Inc. launched UltraGrip, a new nasogastric tube holder designed for secure NG tube placement. This innovative product aims to enhance patient comfort and safety by providing a reliable solution for NG tube securement, reducing the risk of dislodgement and improving patient care.

Analyst Opinion

As per our analyst, the global nasogastric tube market is poised for significant growth, propelled by ongoing technological innovations, the rising prevalence of chronic diseases, and the increasing adoption of enteral feeding solutions. Advancements in biocompatible materials, anti-clogging designs, and closed-system feeding methods are driving patient safety, comfort, and overall market expansion.

Moreover, the growing number of surgical procedures and the rising demand for home healthcare solutions are contributing to the surge in NG tube adoption. However, the market does face challenges, such as the availability of alternative feeding methods like percutaneous endoscopic gastrostomy (PEG) tubes and oral nutritional supplements, which may reduce the reliance on nasogastric tubes.

Despite these challenges, the market is still experiencing substantial growth, especially in the Asia-Pacific region, where expanding healthcare infrastructure, increasing awareness of enteral nutrition, and rising government healthcare investments create ample opportunities for market players. Continued innovations, along with improvements in patient comfort and care, are expected to maintain the positive market trajectory, even amid these hurdles.